Semin Thromb Hemost 2022; 48(05): 497-501
Editorial Compilation XII
1
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, Australia
,
1
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, Australia
,
2
Section of Clinical Biochemistry, University of Verona, Verona, Italy
› Institutsangaben
References
1
Favaloro EJ.
2022 Eberhard F Mammen Award announcements: part I – most popular articles. Semin Thromb Hemost 2022; 48 (05) 502-513
2
Favaloro EJ.
2020 Eberhard F. Mammen Award announcements: part II-Young Investigator Awards. Semin Thromb Hemost 2021; 47 (03) 229-237
3
Al-Samkari H.
Systemic antiangiogenic therapies for bleeding in hereditary hemorrhagic telangiectasia: a practical, evidence-based guide for clinicians. Semin Thromb Hemost 2022; 48 (05) 514-528
4
Samii A,
Norouzi M,
Ahmadi A,
Dorgalaleh A.
Gastrointestinal bleeding in congenital bleeding disorders. Semin Thromb Hemost 2022; 48 (05) 529-541
5
Pedersen OB,
Pasalic L,
Nissen PH,
Grove EL,
Kristensen SD,
Hvas A-M.
Flow cytometric assessment of changes in platelet reactivity after acute coronary syndrome: a systematic review. Semin Thromb Hemost 2022; 48 (05) 542-551
6
Reddel CJ,
Pennings GJ,
Chen VM,
Gnanenthiran S,
Kritharides L.
Colchicine as a modulator of platelet function: a systematic review. Semin Thromb Hemost 2022; 48 (05) 552-567
7
Okholm S,
Krog J,
Hvas A-M.
Tranexamic acid and its potential anti-inflammatory effect: a systematic review. Semin Thromb Hemost 2022; 48 (05) 568-595
8
Driever EG,
Lisman T.
Effects of inflammation on hemostasis in acutely ill patients with liver disease. Semin Thromb Hemost 2022; 48 (05) 596-606
9
Agersnap I,
Nissen PH,
Hvas A-M.
The role of plasminogen activator inhibitor type 1 (PAI-1) in placenta-mediated pregnancy complications: a systematic review. Semin Thromb Hemost 2022; 48 (05) 607-624
10
Daşdemir S,
Kaya Z.
Parathyroid adenoma in a young girl with type 3 von Willebrand disease: comment on “Cancers in patients with von Willebrand disease”. Semin Thromb Hemost 2022; 48 (05) 625-626
11
Franchini M,
Di Perna C,
Santoro C.
et al;
Italian Association of Haemophilia Centres.
Cancers in patients with von Willebrand disease: a survey from the Italian Association of Haemophilia Centres. Semin Thromb Hemost 2016; 42 (01) 36-41
12
Franchini M.
Response to “Parathyroid adenoma in a young girl with type 3 von Willebrand disease”. Semin Thromb Hemost 2022; 48 (05) 627
13
Arachchillage DJ,
Crossette-Thambiah C,
Laffan M.
Lupus anticoagulant and cardiopulmonary bypass. Semin Thromb Hemost 2022; 48 (05) 628-630
